1. A promoter mutation in the haemagglutinin segment of influenza A virus generates an effective candidate live attenuated vaccine. Issue 6 (2nd August 2014) Authors: Harvey, Ruth; Johnson, Rachel E.; MacLellan‐Gibson, Kirsty; Robertson, James S.; Engelhardt, Othmar G. Journal: Influenza and other respiratory viruses Issue: Volume 8:Issue 6(2014:Nov.) Page Start: 605 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Biosafety risk assessment for production of candidate vaccine viruses to protect humans from zoonotic highly pathogenic avian influenza viruses. Issue 2 (28th October 2019) Authors: Chen, Li‐Mei; Donis, Ruben O.; Suarez, David L.; Wentworth, David E.; Webby, Richard; Engelhardt, Othmar G.; Swayne, David E. Journal: Influenza and other respiratory viruses Issue: Volume 14:Issue 2(2020) Page Start: 215 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Comparability of neuraminidase inhibition antibody titers measured by enzyme-linked lectin assay (ELLA) for the analysis of influenza vaccine immunogenicity. Issue 4 (20th January 2016) Authors: Eichelberger, Maryna C.; Couzens, Laura; Gao, Yonghong; Levine, Min; Katz, Jacqueline; Wagner, Ralf; Thompson, Catherine I.; Höschler, Katja; Laurie, Karen; Bai, Tian; Engelhardt, Othmar G.; Wood, John Journal: Vaccine Issue: Volume 34:Issue 4(2016) Page Start: 458 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Comparison of single radial immunodiffusion, SDS-PAGE and HPLC potency assays for inactivated influenza vaccines shows differences in ability to predict immunogenicity of haemagglutinin antigen. Issue 29 (5th July 2018) Authors: Engelhardt, Othmar G.; Edge, Chantal; Dunleavy, Una; Guilfoyle, Kate; Harvey, Ruth; Major, Diane; Newman, Robert; Penn, Rebecca; Skeldon, Sarah; Storey, Claire; Wheeler, Jun; Wood, John; Minor, Philip Journal: Vaccine Issue: Volume 36:Issue 29(2018) Page Start: 4339 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. CONSISE statement on the reporting of Seroepidemiologic Studies for influenza (ROSES‐I statement): an extension of the STROBE statement. Issue 1 (9th August 2016) Authors: Horby, Peter W.; Laurie, Karen L.; Cowling, Benjamin J.; Engelhardt, Othmar G.; Sturm‐Ramirez, Katharine; Sanchez, Jose L.; Katz, Jacqueline M.; Uyeki, Timothy M.; Wood, John; Van Kerkhove, Maria D. Journal: Influenza and other respiratory viruses Issue: Volume 11:Issue 1(2017) Page Start: 2 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Establishment of the first WHO International Standard for antiserum to Respiratory Syncytial Virus: Report of an international collaborative study. Issue 50 (29th November 2018) Authors: McDonald, Jacqueline U.; Rigsby, Peter; Dougall, Thomas; Engelhardt, Othmar G. Journal: Vaccine Issue: Volume 36:Issue 50(2018) Page Start: 7641 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Expansion of the 1st WHO international standard for antiserum to respiratory syncytial virus to include neutralisation titres against RSV subtype B: An international collaborative study. Issue 4 (22nd January 2020) Authors: McDonald, Jacqueline U.; Rigsby, Peter; Atkinson, Eleanor; Engelhardt, Othmar G. Journal: Vaccine Issue: Volume 38:Issue 4(2020) Page Start: 800 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Many ways to make an influenza virus – review of influenza virus reverse genetics methods. Issue 3 (19th June 2012) Authors: Engelhardt, Othmar G. Journal: Influenza and other respiratory viruses Issue: Volume 7:Issue 3(2013:May) Page Start: 249 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Protective efficacy of a polyvalent influenza A DNA vaccine against both homologous (H1N1pdm09) and heterologous (H5N1) challenge in the ferret model. Issue 34 (9th August 2021) Authors: Guilfoyle, Kate; Major, Diane; Skeldon, Sarah; James, Heather; Tingstedt, Jeanette L.; Polacek, Charlotta; Lassauniére, Ria; Engelhardt, Othmar G.; Fomsgaard, Anders Journal: Vaccine Issue: Volume 39:Issue 34(2021) Page Start: 4903 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Report on eighth WHO meeting on development of influenza vaccines that induce broadly protective and long-lasting immune responses: Chicago, USA, 23–24 August 2016. Issue 7 (8th February 2018) Authors: Ortiz, Justin R.; Hickling, Julian; Jones, Rebecca; Donabedian, Armen; Engelhardt, Othmar G.; Katz, Jacqueline M.; Madhi, Shabir A.; Neuzil, Kathleen M.; Rimmelzwaan, Guus F.; Southern, James; Spiro, David J.; Hombach, Joachim Journal: Vaccine Issue: Volume 36:Issue 7(2018) Page Start: 932 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗